GLP-1 receptor agonists × glycemic control

SynthesisDiabetes, obesity & metabolism2025

Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Jing Ling et al.PubMed ↗Full text ↗Publisher ↗

  • Liraglutide plus metforminlooks good hereLower fasting blood sugar.Randomised, large.

What the trial testedrandomised · 1,657 people · 2025

Randomised vs metformin alone

Lowered fasting blood sugar

−1.92−2.43 to −1.41

liraglutide plus metformin vs metformin alone

As reported

difference −1.92, 95% CI −2.43 to −1.41 · the paper's word: fasting plasma glucose (FPG)

Who was studied, and how

1,657people with type 2 diabetes, in this paper

The trial randomly assignedassigned by chance

liraglutide plus metformin
metformin alone

Lowered fasting blood sugar−1.92

randomised

the abstract, start to end

FPG (standard mean difference = -1.92, 95% confidence interval [CI]

← favours treatmentfavours comparator →
could be chance
Fasting plasma glucose (FPG)liraglutide plus metformin vs metformin alone
−1.92−2.43 to −1.41
MetforminGLP-1 receptor agonistsGlycemic control
1 / 4

5 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40855964